Pharmafile Logo

real-time data

- PMLiVE

Launch excellence: innovative thinking meets insightful strategy

‘True launch excellence demands bold innovation, deep market insight and flawless alignment across product, market and organisational execution’

- PMLiVE

Roche’s Lunsumio receives positive CHMP opinion for follicular lymphoma

The recommendation for the subcutaneous formulation follows encouraging trial data

- PMLiVE

University of Liverpool identifies new class of antibiotic in fight against AMR

The new antibiotic class targets two of the WHO’s ‘priority pathogens’

- PMLiVE

Biopharma 2030 challenge: scaling product launches without growing teams

‘83% of large biopharmas plan to manage more launches without expanding their commercial teams’

- PMLiVE

Ipsen’s tumour treatment receives MHRA marketing authorisation

This is the first approval in the UK for previously treated advanced neuroendocrine tumours

- PMLiVE

New National Commission launched to strengthen AI regulation

The Commission will unite healthcare leaders, regulators and technology experts to shape future AI governance

- PMLiVE

Will data and AI prove to be the game-changer that transforms launch excellence?

Investing in data analytics and AI tools can lead to smarter clinical trials and faster, more informed decisions

- PMLiVE

New survey: Europeans seek better health equity in breast cancer awareness

‘More than 558,000 new breast cancer cases are diagnosed annually and the disease claims around 145,000 lives each year’

- PMLiVE

Novartis announces new data supporting MS therapy Kesimpta

The latest trial results reinforce the drug's long-term efficacy and safety profile

- PMLiVE

EMA reaffirms guidance on paracetamol use during pregnancy

The guidance follows recent US comments about a possible link to autism

- PMLiVE

Lilly to spend $6.5bn on second of four US manufacturing facilities

The new facility in Texas is expected to create 4,615 manufacturing and construction jobs

- PMLiVE

SAY Communications teams up with Overcoming MS, a multiple sclerosis charity

The MS charity is this year’s recipient of the company’s pro bono programme

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links